Literature DB >> 11171108

Preparation of anhydrothrombin and characterization of its interaction with natural thrombin substrates.

K Hosokawa1, T Ohnishi, M Shima, M Nagata, T Koide.   

Abstract

Thrombin is a serine proteinase that plays a key role in thrombosis and haemostasis through its interaction with several coagulation factors. Anhydrothrombin was prepared from PMSF-inactivated thrombin under alkaline conditions, and the folded anhydrothrombin was successfully recovered after dialysis in the presence of glycerol. Anhydro-derivatives of factor Xa, factor VIIa and activated protein C could also be prepared essentially by the same procedure. Anhydrothrombin retained affinity for various natural substrates of thrombin, including fibrinogen, factor VIII, factor XIII and protein C. In addition, these proteins were bound to anhydrothrombin-agarose in a reversible manner. The K(d) values for factor VIII, fibrinogen, factor XIII and protein C were 1.2x10(-8), 4.4x10(-8), 2.8x10(-7) and 8.1x10(-5) M, respectively. Thus thrombin substrates known to interact with the exosite I of thrombin demonstrated high affinity for anhydrothrombin. Furthermore, in the presence of Na+, substantial enhancement of the association rate constant (k(ass)) was observed for interactions of fibrinogen and factor VIII with anhydrothrombin. These results suggest that anhydrothrombin is useful in the purification of thrombin substrate proteins as well as in the investigation of detailed interactions between thrombin and these substrates in their activation or degradation processes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11171108      PMCID: PMC1221657          DOI: 10.1042/0264-6021:3540309

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  Computing in clinical departments: implications for the design of hospital information systems.

Authors:  D G Wastell; E J Acheson; L Cotter; W Schady; S B Lucas; E Cronin
Journal:  Health Policy       Date:  1987       Impact factor: 2.980

2.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation.

Authors:  T K Vu; D T Hung; V I Wheaton; S R Coughlin
Journal:  Cell       Date:  1991-03-22       Impact factor: 41.582

3.  Preparation of anhydro-thrombin and its interaction with plasma antithrombin III.

Authors:  T Tomono; E Sawada
Journal:  Nihon Ketsueki Gakkai Zasshi       Date:  1986-07

4.  Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C.

Authors:  N L Esmon; W G Owen; C T Esmon
Journal:  J Biol Chem       Date:  1982-01-25       Impact factor: 5.157

Review 5.  The clot thickens: clues provided by thrombin structure.

Authors:  M T Stubbs; W Bode
Journal:  Trends Biochem Sci       Date:  1995-01       Impact factor: 13.807

6.  Preparation and characterization of anhydrothrombin.

Authors:  R W Ashton; H A Scheraga
Journal:  Biochemistry       Date:  1995-05-16       Impact factor: 3.162

7.  Refined structure of the hirudin-thrombin complex.

Authors:  T J Rydel; A Tulinsky; W Bode; R Huber
Journal:  J Mol Biol       Date:  1991-09-20       Impact factor: 5.469

8.  Thrombin is a Na(+)-activated enzyme.

Authors:  C M Wells; E Di Cera
Journal:  Biochemistry       Date:  1992-12-01       Impact factor: 3.162

9.  Monoclonal antibodies to porcine factor VIII coagulant and their use in the isolation of active coagulant protein.

Authors:  D N Fass; G J Knutson; J A Katzmann
Journal:  Blood       Date:  1982-03       Impact factor: 22.113

10.  The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment.

Authors:  W Bode; I Mayr; U Baumann; R Huber; S R Stone; J Hofsteenge
Journal:  EMBO J       Date:  1989-11       Impact factor: 11.598

View more
  1 in total

1.  Restricted active site docking by enzyme-bound substrate enforces the ordered cleavage of prothrombin by prothrombinase.

Authors:  Ayse Hacisalihoglu; Peter Panizzi; Paul E Bock; Rodney M Camire; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2007-09-11       Impact factor: 5.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.